BRCA2 and cancer: Driver lesions are believed to play an important role in subclone proliferation advantage and tumorigenesis12, such as mutations of TP53 and BRAF, which appear in a wide range of cancer types, as well as BRCA1 and BRCA2 mutations in breast cancer13 and APC mutations in adenomatous polyposis14.